PDGF antagonists (Sanofi)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePDGF antagonists (Sanofi)
Drug Alias NamePDGF antagonist (Aventis)PDGF antagonist (sanofi-aventis)platelet derived growth factor antagonist (Aventis)SAR-109511TKI-963
ClassificationSmall molecules
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptor
Therapy Area/IndicationsMyeloproliferative DisordersCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiAventis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMyeloproliferative DisordersCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A